跳至主要内容
临床试验/JPRN-UMIN000035990
JPRN-UMIN000035990已完成未知

Practice in the Radiation Therapy for Stage D1 Prostate Cancer: Survey of the Japanese Radiation Oncology Study Group (JROSG) - D1 prostate

ihon University school of medicine0 个研究点目标入组 169 人开始时间: 2019年2月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
169

研究概览

简要总结

The median follow-up period was 53 months (range, 9-99). Estimated 5-year overall and progression free survival rates were 84.6% and 69.3%, respectively. Fifty-one (30.2%) patients developed biochemical recurrence.Multivariate analyses indicated that BED was the only significant prognostic factor for overall survival (p=0.01) and DSS (p=0.04).

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
Male

入选标准

  • 未提供

排除标准

  • There is no pathological diagnosis Patients undergoing surgery for prostate cancer

研究者

发起方
ihon University school of medicine

相似试验